✦ LIBER ✦

72 Targeting the cell cycle in combination with radiotherapy or chemotherapy

✍ Scribed by G.A. McArthur; A. Deans; J. Raleigh; C. Cullinane; D. Dorow; N. Conus; R. Hicks

Book ID: 119517618
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 136 KB
Volume: 78
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(06)80566-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential combination chemotherapy with

Sequential combination chemotherapy with or without radiotherapy in small cell lung cancer (SCLC)

✍ N. Niederle; J. Schütte; W. Alberti; S. Seeber; H. Hirche; W. Eberhardt; H. Höfe 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 137 KB

Radiotherapy alone vs. radiotherapy comb

Radiotherapy alone vs. radiotherapy combined with chemotherapy in non-small cell lung cancer (NSCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Combination chemotherapy followed by sur

Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer

✍ F. KIRSTEN; K.H. ATKINSON; J. V. M. COPPLESON; P. M. ELLIOTT; D. GREEN; R. HOUGH 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

To combine or not combine: the role of r

To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma

✍ Weiss, Christian; Schulze, BjÃ¶rn; Ottinger, Annette; RÃ¶del, Claus 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 859 KB

Role of radiotherapy in combination with

Role of radiotherapy in combination with chemotherapy, targeted therapy, and immunotherapy in the management of pancreatic cancer

✍ Sharabi, Andrew; Herman, Joseph; Weiss, Vivian; Laheru, Daniel; Tuli, Richard 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 811 KB

Combination chemotherapy with cisplatin

Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer

✍ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)